Latest filing published 09 Nov 2006 for COLLAGENEX PHARMACEUTICALS INC, €114k.
Insider track record
No signal scores available.
James E. Daverman: trading record in brief
James E. Daverman discloses dealings in Collagenex Pharmaceuticals Inc to SEC (Form 4). In total, 10 filings cover trades dated from 20 June 2006 to 9 November 2006.
The open-market record consists of 8 sales worth €229k, with no purchase. Outside the open market, there are 2 option exercises.
The latest filing, published on 9 November 2006, reports an option exercise of €114k in Collagenex Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to James E. Daverman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,000 shares@ US$9.75Common StockSEC:0001179110-06-021404:0
- 13,000 shares@ US$13.06Common StockSEC:0001179110-06-018798:0
- 100 shares@ US$12.03Common StockSEC:0001179110-06-013896:4
- 10,000 shares@ US$10.00Common StockSEC:0001179110-06-013896:0
- 1,700 shares@ US$12.10Common StockSEC:0001179110-06-013896:1
- 300 shares@ US$12.12Common StockSEC:0001179110-06-013896:2
- 1,900 shares@ US$12.02Common StockSEC:0001179110-06-013896:3
- 2,000 shares@ US$12.03Common StockSEC:0001179110-06-013896:5
- 2,000 shares@ US$12.00Common StockSEC:0001179110-06-013896:6
- 2,000 shares@ US$11.95Common StockSEC:0001179110-06-013896:7
10 of 10 declarations